HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...
InvestorsHub on MSN

HCW Biologics highlights positive findings for CAR-T therapy manufacturing

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...
STAT

What does ‘bona fide competition’ actually mean in the biologics market?

On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare ...
STAT

From bench to bedside, biologics require excellence at every stage

The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...
Medscape

Biologics vs Phototherapy in Psoriasis: Cost-Benefit Analysis Highlights Divergent Patient and Payer Incentives

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.
Self

10 Questions to Ask Your Doctor Before Taking Biologics for Psoriasis10 Questions to Ask Your Doctor Before Taking Biologics for Psoriasis

Just how like finding the perfect shade of foundation or the holy grail of running shoes can take a bit of trial and error, so can finding the right treatment for an autoimmune disease like psoriasis.